Distribution of human chemokine (C-X3-C) receptor 1 (CX 3CR1) gene polymorphisms and haplotypes of the CC chemokine receptor 5 (CCR5) promoter in Chinese people, and the effects of CCR5 haplotypes on CCR5 expression

International Journal of Immunogenetics

Volumn 32, Issue 2, 2005, Pages 99-106

  Li, C ^a   Lu, S C ^b   Hsieh, P S ^a   Huang, Y H ^a   Huang, H I ^a   Ying, T H ^a   Shieh, B ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLELE; ARTICLE; CAUCASIAN; CHINESE; FLUORESCENCE ACTIVATED CELL SORTING; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TAIWAN;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HAPLOTYPES; HIV INFECTIONS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 16244415867     PISSN: 17443121     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2005.00498.x     Document Type: Article

References (31)

1. Achord, A.P., Lewis, R.E., Brackin, M.N. & Cruse, J.M. (1997) HLA-DQB1 markers associated with human immunodeficiency virus type I disease progression. Pathobiology, 65, 210.
2. An, P., Martin, M.P., Nelson, G.W., Carrington, M., Smith, M.W., Gong, K., Vlahov, D., O'Brien, S.J. & Winkler, C.A. (2000) Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans. AIDS, 14, 2117.
3. Benkirane, M., Jin, D.Y., Chun, R.F., Koup, R.A. & Jeang, K.T. (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5A32. Journal of Biological Chemistry, 272, 30603.
4. Candore, G., Romano, G.G., D'Anna, C., Di Lorenzo, G., Gervasi, F., Lio, D., Modica, M.A., Potestio, M. & Caruso, C. (1998) Biological basis of the HLA-B8,DR3-associated progression of acquired immune deficiency syndrome. Pathobiology, 66, 33.
5. Carrington, M., Nelson, G. W., Martin, M.P., Kissner, T., Vlahov, D., Goedert, J.J., Kaslow, R., Buchbinder, S., Hoots, K. & O'Brien, S.J. (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science, 283, 1748.
6. Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R. et al. (1996) Genetic restriction of HLV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273, 1856.
7. Faure, S., Meyer, L., Costagliola, D., Vaneensberghe, C., Genin, E., Autran, B. et al. (2000) Rapid progression to AIDS in HLV* individuals with a structural variant of the chemokine receptor CX3CR1. Science, 287, 2274.
8. Faure, S., Meyer, L., Genin, E., Pellet, P., Debré, P., the Seroco Study Group, Théodorou, I. & Combadière, C. (2003) Deleterious genetic influence of CX3CR1 genotypes on HLV-1 disease progression. Journal of Acquired Immunodeficiency Syndrome, 32, 335.
9. Hampe, J., Lynch, N.J., Daniels, S., Bridger, S., Macpherson, A.J.S., Stokkers, P. et al. (2001) Fine mapping of chromosome 3p susceptibility locus in inflammatory bowel disease. Gut, 2001, 191.
10. 3CR1 polymorphism. Journal of Acquired Immunodeficiency Syndrome, 26, 507.
11. Huang, Y., Paxton, WA., Wolinsky, S.M., Neumann, A.U., Zhang, L., He, T. et al. (1996) The role of a mutant CCR5 allele in HLV-1 transmission and disease progression. Nature Medicine, 2, 1240.
12. Kholodnyuk, I.D., Kost-Alimova, M., Yang, Y., Kiss, H., Fedorova, L., Klein, G. & Imreh, S. (2002) The microcell hybrid-base 'Elimination Test' identifies a 1-Mb putative tumor-suppressor region at 3p22.2-p22.1 centromeric to the homozygous deletion region detected in lung cancer. Genes, Chromosomes and Cancer, 34, 341.
13. Kostrikis, L.G., Huang, Y., Moore, J.P., Wolinsky, S.M., Zhang, L., Guo, Y., Deutsch, L., Phair, J., Neumann, A.U. & Ho, D.D. (1998) A chemokine receptor CCR2 allele delays HLV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Medicine, 4, 350.
14. Kwa, D., Boeser-Nunnink, B. & Schuitemaker, H. (2003) Lack of evidence for an association between a polymorphism in CX3CR1 and the clinical course of HIV infection or virus phenotype evolution. AIDS, 17, 759.
15. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., Macdonald, M.E., Stuhlmann, H., Koup, R.A. & Landau, N.R. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell, 86, 367.
16. Maho, A., Bensimon, A., Vassart, G. & Parmentier, M. (1999) Mapping of the CCXCR1, CX3CR1, CCBP2 and CCR9 genes to the CCR cluster within the 3p21.3 region of the human genome. Cytogenetics and Cell Genetics, 87, 265.
17. Martin, M.P., Dean, M., Smith, M.W., Winkler, C., Gerrard, B., Michael, N.L. et al. (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science, 282, 1907.
18. McDermott, D.H., Colla, J.S., Kleeberger, C.A., Plankey, M., Rosenberg, P.S., Smith, E.D. et al. (2000) Genetic polymorphism in CX3CR1 and risk of HIV disease. Science, 290, 2031.
19. McDermott, D.H., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Merrell, M.N., Epstein, N., Quyyumi, A.A. & Murphy, P.M. (2001) Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circulation Research, 89, 401.
20. McDermott, D.H., Zimmerman, P.A., Guignard, F., Kleeberger, C.A., Leitman, S.F. & the Multicenter Aids Cohort Studies & Murphy, P.M. (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Lancet, 352, 866.
21. O'Brien, S.J. (1998) AIDS: a role for host genes. Hospital Practice, 33, 53.
22. O'Brien, S.J. & Moore, J.P. (2000) The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunological Reviews, 177, 99.
23. Ometto, L., Bertorelle, R., Mainardi, M., Zanchetta, M., Tognazzo, S., Rampon, O., Ruga, E., Chieco-Bianchi, L. & De Rossi, A. (2001) Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children. Journal of Infectious Diseases, 183, 814.
24. Quillent, C., Oberlin, E., Braun, J., Rousset, D., Gonzalez-Canali, G., Metais, P., Montagnier, L., Virelizier, J.L., Arenzana-Seisdedos, F. & Beretta, A. (1998) HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet, 351, 14.
25. de Roda Husman, A.M., Koot, M., Cornelissen, M., Keet, I.P., Brouwer, M., Broersen, S.M. et al. (1997) Association between CCR5 genotype and the clinical course of HIV-1 infection. Annuals of International Medicine, 127, 882.
26. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.M. et al. (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 382, 722.
27. Shieh, B., Yan, Y.P., Liau, Y.E., Wang, S.T. & Li, C. (2000) Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. International Immunology, 12, 1311.
28. Smith, M.W., Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Lomb, D.A. et al. (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science, 277, 959.
29. Winchester, R., Chen, Y., Rose, S., Selby, J. & Borkowsky, W. (1995) Major histocompatibility complex class II DR alleles DRB2*2502 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: Determination by an automated sequence-base typing method. Proceedings of the National Academy of Sciences of the United States of America, 92, 12374.
30. Winkler, C., Modi, W., Smith, M.W., Nelson, G.W., Wu, X., Carrington, M. et al. (1998) Genetic restriction of AIDS pathogenesis by an SDF-I chemokine gene variant. Science, 279, 389.
31. Wu, L., Paxton, W.A., Kassam, N., Ruffing, N., Rottman, J.B., Sullivan, N. et al. (1997) CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1 in vitro. Journal of Experimental Medicine, 185, 1681.